AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT04744077 — intervention group
Intervention type: BEHAVIORAL
Group type: SHAM_COMPARATOR
Intervention: Influencer Instagram account
Description: Participants randomized to this group will follow a public Instagram account. This account was chosen because they have a strong following (over 600,000 followers) and it is a public account that anyone can follow. The content shared on this page is motivational and community driven. There is a focus of healthy living with an emphasis on exercise. Additionally, there are no paid sponsorships or radical exercise advice, which is common on other influencer pages. The Co-PIs determined that this page accurately represents the exercise-related content that is readily available on Instagram. The research team will not have control over the content of this account, but the account holder will be notified about the study.
Study NCT04744077 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Research study Instagram account
Description: Intervention arms will deliver the same exercise-related content on the same schedule on the intervention Instagram accounts. The arms will deliver 13-weeks worth of content which goes through the last possible day of the intervention. The structure was based on feedback from stakeholders in a formative focus group. All of the content delivered through the accounts is evidence-based and referenced from reputation organizations/agencies such as the American College of Sports Medicine, American Heart Association, Center for Disease Control, and World Health Organization. Each Co-PI will post videos to answer participant questions. To ensure that the content between both groups is the same, the Co-PIs will meet to determine which questions to answer and draft the response.
Study NCT05776485 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Progressive resistance training
Description: Only the control group: 3 exercise bouts within the study period. Comparison between exercised and non-exercised leg.
Study NCT05776485 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Cross-sectional comparison between healthy and tendinopathic group
Description: Comparison of primary and secondary outcomes.
Study NCT06309147 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: BMS-9894923
Description: 50 mg capsules, oral administration
Study NCT06309147 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: BMS-9894923
Description: 50 mg capsules, oral administration
Study NCT05031910 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Medical Device Usage and Evaluation
Description: Undergo virtual reality imaging via VR/3D-CEPs
Study NCT05031910 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Best Practice
Description: Receive standard of care
Study NCT05031910 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Best Practice
Description: Receive standard of care
Study NCT05031910 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Resection
Description: Undergo surgical resection
Study NCT05031910 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Resection
Description: Undergo surgical resection
Study NCT06280365 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Mulligan Mobilization with Movement Technique
Description: Mobilization Technique
Study NCT06168708 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Transurethral resection of the prostate (TURP)
Description: TURP with addition of gentamicin on irrigation fluid to reduce infectious complications
Study NCT06168708 — intervention group
Intervention type: PROCEDURE
Group type: PLACEBO_COMPARATOR
Intervention: Transurethral resection of the prostate (TURP)
Description: TURP with addition of gentamicin on irrigation fluid to reduce infectious complications
Study NCT06168708 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Gentamicin
Description: gentamicin 80 mg (2ml) /3L of irrigation solution (the first 9 Liters during resection and the first 6 Liters during post-operative irrigation)
Study NCT06168708 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: normal saline
Description: normal saline (2 ml) on the irrigation solution (placebo)
Study NCT06182865 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Ga-68 Dolacga Injection
Description: Ga-68 Dolacga will be administered via iv bolus injection followed by a whole-body PET/CT scan for liver reserve evaluation.
Study NCT06349902 — intervention group
Intervention type: BEHAVIORAL
Intervention: Re-Link
Description: The HCV nurse will attempt to contact the PWDU HCV via phone call and text. If unable to connect with a client via phone, an alert is added to the client's chart in the electronic medical record. When the client presents to the CBSUTP for their regular substance use follow up appointment, the chart alert is flagged by the administrative team and the client is connected with the HCV nurse via telemedicine. Clients who are connected to the HCV team are considered re-linked. The HCV nurse will provide an HCV intake as per program guidelines. Clients who would prefer to pursue treatment elsewhere will be supported with a referral to their family doctor or an alternative HCV program in the community. Clients who choose to be treated at the CBSUTP will receive a HCV consultation, DAA treatment and follow-up from the HCV clinical team onsite as per existing program guidelines.
Study NCT05476224 — intervention group
Intervention type: BIOLOGICAL
Intervention: Blood sample of 30 ml
Description: The parameters analyzed on this blood sample: Fasting blood glucose, HbA1C, creatinine, creatinine clearance (MDRD), fasting lipid profile (total cholesterol, HDL cholesterol, LDL cholesterol, triglycerides.
Study NCT05372445 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Non-intensive intervention
Description: After an evaluation of 7 day initial food-recall, subjects will receive counseling in order to improve their dietary habits, according to the American Diabetes Association 2019 Guidelines. The goals of this intervention are (i) achieve a caloric restriction of 500 kcal from their habitual energy intake, (ii) prioritize natural, minimally processed foods with a low glycemic index and glycemic load, (iii) eat lean protein sources, both from plant and animal origin and (iv) gradual increments of fiber intake, to achieve at least the minimum recommendations for the general population.~The frequency of the follow-up appointments will be every 4 weeks, alternating between a clinical control and nutritional one. Therefore, the planned nutritional follow-up frequency will be every 2 months. In these appointments, the objective will be to achieve the mentioned energy intake reduction of 500 kcal, aiming to the nutritional goals previously mentioned, with the aid of the food-recalls.
Study NCT05372445 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Intensive intervention
Description: People will have virtual education with food and nutrition coaching workshops, as well as weekly meetings in small groups as a support and follow-up groups. The frequency of the face-to-face follow-up appointments will be every 3 weeks.~The nutritional intervention will emphasize the consumption of mainly minimally processed food from plant origin. A vitamin b12 supplement per week will be provided. This intervention group will have 2 stages. First stage will have a duration of 3 months setting the nutritional bases going to a plant-based diet with basic considerations regarding fiber intake reducing meat consumption, and incorporating protein from vegetable sources, among other considerations. Second stage will progress to higher levels of fiber and others nutritional requeriments in order to intensify the nutritional plant-based intervention.
Study NCT06149338 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Macintosh laryngoscope
Description: Macintosh laryngoscope has been the gold standard for endotracheal intubation since the middle of 20th century. During laryngoscopy and direct vision of the vocal cords, an endotracheal tube is passed into the trachea, establishing the airway.
Study NCT06149338 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Vie Scope
Description: Vie Scope is a laryngoscope, whose function is relied on Seldinger technique. Firstly, bougie is passed through the translucent barrel of Vie Scope under direct vision between the vocal cords and into the trachea. Then, Vie Scope is removed and an endotracheal tube is passed over the bougie, which will be finally removed. The inflation of the endotracheal tube's cuff is followed by ventilation and confirmation of the tube placement.
Study NCT05603299 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Educational Materials on the Dawn test
Description: Receive educational materials and sample test results replicating what physicians would receive in the real-world market as they learn about the probability of IO therapy response from the Dawn™ test.
Study NCT06334770 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Roxolid implants
Description: four Straumann BLX® roxolid implant 15% zirconium and 85% titanium), 3.7 mm in diameter, and 10 mm in length.implants were selected with the following criteria: tapered, self-tapping, aggressively threaded,were inserted with novalock attachments.
Study NCT06334770 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Titanium implants
Description: four conventional acid etched pure implants tapered, self-tapping, threaded, two-piece, with the 10 mm length and 3.7 mm diameter were inserted with Sphero flex attachments.
Study NCT06478927 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Palbociclib capsules
Description: Palbociclib capsules, oral, 125 mg/dose, qd, take 3 weeks and then stop for 1 week, 28d for one treatment cycle until disease progression or intolerable toxicity.
Study NCT06007573 — intervention group
Intervention type: DRUG
Group type: OTHER
Intervention: The control group received oral nimodipine tablets
Description: The control group received oral nimodipine tablets
Study NCT06007573 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: The control group received oral nimodipine tablets
Description: The control group received oral nimodipine tablets
Study NCT04904601 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: Kale supplement
Description: Kale (blanched freeze-dried Kale) group1
Study NCT04904601 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: Peas supplement
Description: placebo (Blanched Freeze-dried Peas) group2
Study NCT04974359 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Lu AG06466
Description: Lu AG06466 - capsules
Study NCT04974359 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo - capsules
Study NCT00013182 — intervention group
Intervention type: BEHAVIORAL
Group type: OTHER
Intervention: social activity
Study NCT06317766 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: 2910 nm Fiber Laser Treatment; Pre-Clinical Histology Evaluation
Description: Treatment with 2910 nm fiber laser focusing on its diverse energy settings and histological evaluation post abdominoplasty.
Study NCT06317766 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: 2910 nm Fiber Laser Treatment; Part 2 Histology Evaluation
Description: Healing Progression: Treatment with 2910 nm fiber laser focusing on its diverse energy settings and histological evaluation post abdominoplasty.
Study NCT05402267 — intervention group
Intervention type: PROCEDURE
Intervention: Adenoidectomy
Description: Adenoidectomy will be conducted in OA and CA groups
Study NCT06497439 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Silfamin
Description: 2 tablets of Silfamin 150 mg twice daily
Study NCT06646783 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: [68Ga]Ga-NODAGA-SNA014
Description: Perform whole-body PET/CT scans on the subjects at 30 minutes (± 5 minutes), 60 minutes (± 10 minutes), 120 minutes (± 20 minutes), and 240 minutes (± 30 minutes) after administration. Among them, PET scanning can be performed on 1-2 subjects in a certain dose group or each dose group for 30-60 minutes. Among the four CT scans, one CT scan is a conventional low-dose CT scan (120mA), and the remaining three are extremely low-dose CT scans (10-20mA). The main researchers and nuclear medicine physicians can decide whether to change the subsequent image acquisition time and duration of the subjects based on the image information obtained from the enrolled subjects.
Study NCT06407193 — intervention group
Intervention type: OTHER
Intervention: MRI and scintigraphy
Description: Gastric emptying measured with MRI and scintigraphy
Study NCT06497439 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo tablet of Silfamin
Description: 2 tablets of Silfamin Placebo twice daily
Study NCT04634201 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Oral probiotics (L. reuteri)
Description: administration of probiotic containing tablets twice daily after tooth brushing for 3 months
Study NCT04634201 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: SHAM_COMPARATOR
Intervention: Placebo
Description: administration of a placebo twice daily after tooth brushing for 3 months
Study NCT06457542 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Active Release Technique
Description: Active Release Therapy, which involves instructing the patient to sit and then positioning their shoulder in 90-degree abduction. The therapist will provide assistance to the patient's arm and then examine the supraspinous fossa by applying pressure with a finger. The patient will be instructed to gradually bring the arm towards the body as the therapist manipulates the muscle plane. This procedure should be repeated for a duration of 10 minutes, 3 times per week, over a duration of four weeks.
Study NCT06457542 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Soft Tissue Mobilization
Description: Soft Tissue Mobilization (STM) targeting the subscapularis muscle. The participants will be placed in a position where their upper arm bone (humerus) is raised at a 45° angle, with the elbow bent at a 90° angle. Additionally, the humerus will be rotated outward to a position that is normally around 20° to 25° of external rotation. The subscapularis muscle remained examined by touch in the armpit area to locate regions of limited mobility due to myofascial limitations, trigger points or tense bands. The identified limitations remained addressed with STM, which included applying prolonged manual pressure and slow deep stroke to the subscapularis myofascial. This treatment was performed for a period of 7 minutes, three times a week, over a period of four weeks.
Study NCT05652751 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: nerve growth factor
Description: The patient first received an intramuscular injection of NGF or saline into the gluteus maximus.The 20ug nerve growth factor (NO.S20060051, Jinlujie) will be obtained from Hiteck Biopharmaceutical Co., Ltd, Wuhan, China. mNGF will be dissolved in 1 ml sterile water for injection and then injected intramuscularly at gluteal muscle, once a day for 4 weeks. Dose modification is not allowed for mNGF.
Study NCT05652751 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: physiological saline
Description: Other patients will receive 1ml volume of physiological saline (PS) injected into the gluteal muscle, once a day for 4 weeks.
Study NCT05652751 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: physiological saline
Description: Other patients will receive 1ml volume of physiological saline (PS) injected into the gluteal muscle, once a day for 4 weeks.
Study NCT05652751 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: EA
Description: Patients take supine position. After skin disinfection with 75% ethanol routine disinfection, the stainless needle (size 0.25mm×40mm, Hua Tuo brand, Suzhou Medical Supplies Company Ltd in Jiangsu, China) will be inserted in GV20（Baihui) and the stainless needle(size 0.25mm×25mm, described above) will be inserted in GV26 (Shuigou), acupoints will be stimulated manually until patients feel soreness, distension or heaviness (the reaction of De Qi). Then, the needles are stimulated by using an acupuncture point nerve stimulator (HANS-200, Nanjing Jinsheng, Ltd., China) with a frequency of 2/100 Hz and an intensity of 3 mA for 40 min (a homemade relay cycled power to the electrode for 6 sec on and 6 sec off), 28 days as a course of treatment, once a day.
Study NCT06221345 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Systane HYDRATION® Preservative-Free Lubricant Eye Drops
Description: The HPG/HA group will receive Systane HYDRATION® Preservative-Free Lubricant Eye Drops and standard of care, i.e., prednisolone acetate (Pred forte®) and levofloxacin (Cravit®), at the dosage of 1-2 drops 4 times daily for 3 weeks from Weeks 1 to 4 post-op
Study NCT06221345 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Optive Fusion® Lubricant Eye Drops (Unit Dose)
Description: The CMC/HA group will receive Optive Fusion® Lubricant Eye Drops (Unit Dose) and standard of care, i.e., prednisolone acetate (Pred forte®) and levofloxacin (Cravit®), at the dosage of 1-2 drops 4 times daily for 3 weeks from Weeks 1 to 4 post-op
Study NCT04918537 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Walnuts
Description: 30g of plain walnuts in addition to habitual food intakes
Study NCT05527691 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: SupportGroove
Description: An app-delivered program consisting of positive psychology-based activities, such as expressing gratitude, finding meaning, savoring, and fostering connections. Participants complete daily quests suggested through the app, some of which are completed on their own, and some with their partner.
Study NCT06061718 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: iDose TR
Description: anchored intracameral implant containing travoprost
Study NCT06567093 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Baby Foot and Leg Massage
Description: Baby Foot Massage stages~* The baby is placed on his back, either on the bed or on the couch.~* One of the baby's feet is lifted into the air by grasping the back of the ankle.~* Start stroking with circular movements, starting from the heel and moving up to the toes. Stroking should be done with the thumb.~* Here, it might be good to get between the toes.~* The same procedure is applied to the other foot.~* Massage is continued until it is noticed that the baby calms down.~Baby Leg Massage stages~* Start by lifting the leg to be massaged.~* Here, the palms of both hands are used. The baby's leg is placed between both hands and the leg is stroked by moving the palms in opposite directions. This movement is continued from above the ankle to the hip.~* The same procedure is applied to the other leg.~* Massage is continued until the baby calms down.
Study NCT05652751 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: sham EA
Description: The only difference between sham EA intervention and EA intervention is that the stimulator is connected to the needle handle without power for 40 min intervention.
Study NCT05652751 — intervention group
Intervention type: DEVICE
Group type: PLACEBO_COMPARATOR
Intervention: sham EA
Description: The only difference between sham EA intervention and EA intervention is that the stimulator is connected to the needle handle without power for 40 min intervention.
Study NCT06385418 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Colonic local administration of fluorouracil with enhanced adhesion
Description: Fluorouracil is administered via the colon as an injectable solution at a dose of 500 mg per day for 6 days, along with poloxamer 407 and poloxamer 188 used as thermosensitive hydrogel to enhance adhesion.
Study NCT05888402 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Toripalimab
Description: Two cycles of induction Toripalimab (240mg every 3 weeks) plus platinum-based doublet chemotherapy as induction chemoimmunotherapy.
Study NCT05888402 — intervention group
Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: Concurrent chemoradiation therapy and consolidation immunotherapy
Description: Thoracic radiation therapy (54-66Gy/25-33F/5-7week), concurrently with platinum-based doublet chemotherapy, followed by consolidation Toripalimab (240mg every 3 weeks) as consolidation immunotherapy for up to 12 months.
Study NCT05888402 — intervention group
Intervention type: RADIATION
Group type: ACTIVE_COMPARATOR
Intervention: Concurrent chemoradiation therapy and consolidation immunotherapy
Description: Thoracic radiation therapy (54-66Gy/25-33F/5-7week), concurrently with platinum-based doublet chemotherapy, followed by consolidation Toripalimab (240mg every 3 weeks) as consolidation immunotherapy for up to 12 months.
Study NCT05642663 — intervention group
Intervention type: DEVICE
Intervention: Stapler
Description: Stapling performed with ALTUS Powered Stapler
Study NCT04775368 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Administering diagnosis orientation questionnaires for the screening of possible sleep disorders
Description: Several diagnosis orientation self-questionnaires will be conducted by the patient following his or her inclusion in order to detect, among other things, possible sleep disorders.
Study NCT05795517 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: HSK31679 low dose
Description: HSK31679 low dose and placebo of HSK31679 ，QD，oral，Day1 to week 12
Study NCT05795517 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: HSK31679 medium dose
Description: HSK31679 medium dose and placebo of HSK31679 ，QD，oral，Day1 to week 12
Study NCT05795517 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: HSK31679 high dose
Description: HSK31679 high dose and placebo of HSK31679 ，QD，oral，Day1 to week 12
Study NCT05795517 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: placebo ，QD，oral，Day1 to week 12
Study NCT05795517 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Ezetimibe 10mg
Description: Ezetimibe 10mg+placebo of HSK31679 ，QD，oral，Day1 to week 12
Study NCT03376984 — intervention group
Intervention type: COMBINATION_PRODUCT
Group type: EXPERIMENTAL
Intervention: ND and AMOX modified Gutta Percha
Description: Gutta percha reinforced and modified with 5 nm diameter nanodiamonds and amoxicillin